Literature DB >> 18162943

Passive antibody prophylaxis for RSV.

John DeVincenzo1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18162943     DOI： 10.1097/INF.0b013e318160921e

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  4 in total

1.  Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model.

Authors:  Hayat Caidi; Congrong Miao; Natalie J Thornburg; Ralph A Tripp; Larry J Anderson; Lia M Haynes
Journal:  Antiviral Res       Date:  2018-04-17       Impact factor: 5.970

2.  Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats.

Authors:  Xiaoyan Zhan; Karen S Slobod; Bart G Jones; Robert E Sealy; Toru Takimoto; Kelli Boyd; Sherri Surman; Charles J Russell; Allen Portner; Julia L Hurwitz
Journal:  Int Immunol       Date:  2014-12-04       Impact factor: 4.823

Review 3.  Progress towards recombinant anti-infective antibodies.

Authors:  Jennifer C Pai; Jamie N Sutherland; Jennifer A Maynard
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2009-01

4.  Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.

Authors:  Bart G Jones; Robert E Sealy; Sherri L Surman; Allen Portner; Charles J Russell; Karen S Slobod; Philip R Dormitzer; John DeVincenzo; Julia L Hurwitz
Journal:  Vaccine       Date:  2014-04-14       Impact factor: 3.641
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.